🇺🇸 FDA
Patent

US 8796435

Modular functional peptides for the intracellular delivery of nanoparticles

granted A61KA61K47/6921A61K49/0093

Quick answer

US patent 8796435 (Modular functional peptides for the intracellular delivery of nanoparticles) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K47/6921, A61K49/0093